Literature DB >> 17912037

E2F-dependent induction of p14ARF during cell cycle re-entry in human T cells.

Ana Gutierrez del Arroyo1, Selma El Messaoudi, Paula A Clark, Marion James, Francesca Stott, Adrian Bracken, Kristian Helin, Gordon Peters.   

Abstract

The ARF protein, encoded by alternate exon usage within the CDKN2A locus, provides a link between the retinoblastoma (pRb) and p53 tumor suppressor pathways. Agents that disable pRb or otherwise impinge on the E2F family of transcription factors induce expression of ARF, resulting in stabilization of p53 and activation of p53-regulated genes. However, in some cell types ARF is not induced upon cell cycle re-entry, as expected of a conventional E2F target gene, leading to the suggestion that the ARF promoter only responds to supra-physiological or aberrant levels of E2F. These properties have recently been attributed to a variant E2F binding site but attempts to map specific response elements within the ARF promoter have generally yielded confusing answers. Here we show that in IL2-dependent T-lymphocytes, ARF expression is induced as cells progress from G(0) into S phase, in parallel with other bona fide E2F target genes. This is accompanied by increased association of E2F1 with the endogenous ARF promoter. Our findings suggest that the ability of ARF to register normal proliferative cues depends on the levels of E2F generated in different settings and argue against the idea that it reacts exclusively to oncogenic signals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912037     DOI: 10.4161/cc.6.21.4857

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.

Authors:  A Kumari; T Iwasaki; S Pyndiah; E K Cassimere; C D Palani; D Sakamuro
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

2.  The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.

Authors:  K Evangelou; J Bartkova; A Kotsinas; I S Pateras; M Liontos; G Velimezi; M Kosar; T Liloglou; I P Trougakos; L Dyrskjot; C L Andersen; M Papaioannou; Y Drosos; G Papafotiou; Z Hodny; B Sosa-Pineda; X-R Wu; A Klinakis; T Ørntoft; J Lukas; J Bartek; V G Gorgoulis
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

3.  Elimination of p19ARF-expressing cells enhances pulmonary function in mice.

Authors:  Michihiro Hashimoto; Azusa Asai; Hiroyuki Kawagishi; Ryuta Mikawa; Yuji Iwashita; Kazuki Kanayama; Kazushi Sugimoto; Tadashi Sato; Mitsuo Maruyama; Masataka Sugimoto
Journal:  JCI Insight       Date:  2016-08-04

4.  Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor.

Authors:  Selma El Messaoudi-Aubert; James Nicholls; Goedele N Maertens; Sharon Brookes; Emily Bernstein; Gordon Peters
Journal:  Nat Struct Mol Biol       Date:  2010-06-13       Impact factor: 15.369

5.  E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation.

Authors:  Abel L Carcagno; Mariela C Marazita; María F Ogara; Julieta M Ceruti; Silvina V Sonzogni; María E Scassa; Luciana E Giono; Eduardo T Cánepa
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

6.  Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus.

Authors:  Goedele N Maertens; Selma El Messaoudi-Aubert; Tomas Racek; Julie K Stock; James Nicholls; Marc Rodriguez-Niedenführ; Jesus Gil; Gordon Peters
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

7.  The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells.

Authors:  Salma Siddiqui; Stephen J Libertini; Christopher A Lucas; Alan P Lombard; Han Bit Baek; Rachel M Nakagawa; Kristine S Nishida; Thomas M Steele; Frank U Melgoza; Alexander D Borowsky; Blythe P Durbin-Johnson; LiHong Qi; Paramita M Ghosh; Maria Mudryj
Journal:  Cancer Lett       Date:  2020-04-21       Impact factor: 8.679

8.  Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.

Authors:  Maria Vivo; Michela Ranieri; Federica Sansone; Cristina Santoriello; Raffaele A Calogero; Viola Calabrò; Alessandra Pollice; Girolama La Mantia
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

9.  Arf induction by Tgfβ is influenced by Sp1 and C/ebpβ in opposing directions.

Authors:  Yanbin Zheng; Caitlin Devitt; Jing Liu; Nida Iqbal; Stephen X Skapek
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration.

Authors:  Robert G Hesse; Gayle K Kouklis; Nadav Ahituv; Jason H Pomerantz
Journal:  Elife       Date:  2015-11-17       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.